Decoy Therapeutics Inc. (DCOY) Operating income 2016–2025
Decoy Therapeutics Inc. (DCOY) annual operating income history from SEC filings — each fiscal year as reported.
-$12.6MFY2025 · since FY2016: -$39.9M → -$12.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$12.6M | -120.0% |
| FY2024 | -$5.7M | +55.5% |
| FY2023 | -$12.9M | +59.5% |
| FY2022 | -$31.8M | -148.5% |
| FY2021 | -$12.8M | -64.6% |
| FY2020 | -$7.8M | +5.8% |
| FY2019 | -$8.3M | -390.6% |
| FY2018 | -$1.7M | +95.1% |
| FY2017 | -$34.7M | +12.9% |
| FY2016 | -$39.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice